CD5L and ovarian cancer: To elucidate the downstream effects of blocking endothelial CD36-mediated CD5L signaling, we obtained an endothelial-specific CD36flox/flox knockout mouse model CD36ffTie2Cre (Fig. S10) and inoculated the mice with syngeneic murine ovarian cancer ID8-Luc cells10.